Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting
Abstract Dual-target chimeric antigen receptor T (CAR-T) cell therapy has emerged as a promising strategy to address the key limitations of single-target CAR-T approaches, including antigen heterogeneity and antigen-negative escape. Recent studies have reported rapid progress in the engineering of d...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-06-01
|
| Colecção: | Experimental Hematology & Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s40164-026-00790-4 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|